XILLIX TECHNOLOGIES CORP. is focused on the research, development and commercialization of medical imaging technologies which aid in the early detection and localization of cancer.
Industry: Other Services (Medical Services)
Symbol: t.XLX
Exchange(s): Toronto Stock Exchange
ANNUAL FINANCIALS
Dec 31, 2004
12 Months
C$ Dec 31, 2003
12 Months
C$ Dec 31, 2002
12 Months
C$ 3Yr.
Growth
% Change
Total Revenue ($000): 944 194 263 22.44
Earnings before Interest & Tax ($000): -9,996 -10,018 -5,572 N/A
Profit/Loss ($000): -10,157 -10,142 -5,710 N/A
Earnings per Share: -0.08 -0.11 -0.14 N/A
Total Assets ($000): 22,368 11,364 11,134 68.21
Dividends Per Share 0.00 0.00 0.00
Return on Com. Equity: -83.18 -114.28 -84.54
Employees: 50 50 35
Trailing 12 Month Results
12 Months ended
Sep 30, 2005, C$ 12 Months ended
Sep 30, 2004, C$ %Change
Total Revenue ($000): 2,280 920 147.91
Profit/Loss ($000): -11,194 -10,728 -4.34
Earnings per Share: -0.08 -0.10 20.00
Dividends Per Share 0.00 0.00
Number of Shares: 129,232,515 126,925,415
COMPANY INFORMATION
Key Personnel
CEO: Cynthia Roney, President & C.E.O.
CFO: Brett Gannon, C.O.O. C.F.O. & Secretary
HR: Maureen Tweedly, H.R.
Contact Information
Address: Suite 100,
13775 Commerce Parkway,
Richmond,
BC,
V6V 2V4 Phone: 604-278-5000
Fax: 604-278-3356
Web Address: www.xillix.com
E-Mail : info@xillix.com
Investor
Relations: Sonja Rematore, 604-278-5000
Company Type: Public Company Status: Active
Auditors: Ernst & Young
Transfer Agent: Cibc Mellon Trust Company Vancouver
Incorporation: Canada, Nov 2, 1990
Securities: XLX-T